Skip to main content

Table 4 Univariate and multivariate analysis (Cox proportional-hazard)

From: Unplanned hospitalizations in patients with locoregionally advanced head and neck cancer treated with (chemo)radiotherapy with and without prophylactic percutaneous endoscopic gastrostomy

Variable

TRUH1

TRUH2

OS

HR (95% CI)

P value

HR (95% CI)

P value

HR (95% CI)

P value

Univariate

 Age, years

  ≤ 60

0.76 (0.48–1.18)

.21

0.74 (0.35–1.56)

.42

0.63 (0.42–0.96)

.0288

  > 60–≤ 70

1.00 (0.64–1.58)

.99

1.07 (0.51–2.67)

.86

0.92 (0.60–1.40)

.6884

  > 70–≤ 80

1.43 (0.82–2.50)

.20

1.59 (0.65–3.91)

.30

1.40 (0.84–2.34)

.1937

  > 80

1.52 (0.61–3.75)

.35

0.80 (0.11–5.85)

.82

4.25 (2.26–7.99)

.0001

 ECOG PS at first consultation, (vs other PS)

  0

0.95 (0.60–1.51)

.83

0.89 (0.41–1.91)

.76

0.64 (0.41–1.00)

.0475

  1 (vs others)

0.73 (0.47–1.14)

.16

0.59 (0.28–1.26)

.17

1.05 (0.71–1.58)

.7939

  2/3 (vs others)

1.99 (1.15–3.45)

.01

2.77 (1.23–6.27)

.01

2.01 (1.21–3.37)

.0061

 Alcohol abuse

  Active

1.16 (0.71–1.88)

.55

0.81 (0.36–1.83)

.60

1.23 (0.78–1.94)

.3783

  Active or in past

1.59 (0.92–2.75)

.09

1.17 (0.48–2.85)

.72

1.33 (0.82–2.16)

.2475

  > 2 units a day (= median)

1.44 (0.81–2.57)

.21

0.84 (0.30–2.35)

.73

1.06 (0.63–1.79)

.8203

 Smoking habits

  Current smoker

1.13 (0.70–1.82)

.61

0.94 (0.41–2.13)

.87

1.06 (0.68–1.66)

.7832

  Current or ex-smoker

1.68 (0.74–3.92)

.20

3.39 (0.46–25.1)

.20

1.14 (0.59–2.21)

.7022

  > 40 pack-years (= median)

1.94 (1.17–3.20)

.01

1.98 (0.81–4.85)

.12

1.01 (0.63–1.63)

.9615

 Tumor localization, yes (vs no)

  Oral cavity

1.06 (0.62–1.81)

.83

0.81 (0.31–2.12)

.67

0.80 (0.48–1.36)

.409

  Oropharynx

0.75 (0.48–1.17)

.19

0.75 (0.36–1.56)

.43

0.63 (0.42–0.95)

.026

  Hypopharynx

1.43 (0.81–2.50)

.20

2.00 (0.86–4.69)

.10

1.81 (1.11–2.93)

.0149

  Larynx

1.21 (0.66–2.23)

.53

0.79 (0.24–2.60)

.69

1.39 (0.81–2.38)

.2251

  Mixed

0.80 (0.25–2.52)

.69

1.60 (0.38–6.73)

.56

1.81 (0.74–4.48)

.1878

 Surgery, yes (vs no)

  Primary oncologic surgery

0.72 (0.42–1.24)

.22

0.47 (0.16–1.34)

.15

0.79 (0.49–1.29)

.3395

  Neck dissection

0.69 (0.44–1.07)

.09

0.47 (0.23–0.96)

.03

0.66 (0.44–0.99)

.0438

  Bilateral ND

1.69 (1.08–2.64)

.00

1.75 (0.84–3.67)

.13

0.92 (0.58–1.45)

.7161

  Tracheostomy

1.78 (1.15–2.77)

.01

2.58 (1.24–5.35)

.01

1.49 (0.98–2.25)

.0594

  pPEG

1.46 (0.93–2.30)

.09

2.56 (1.09–5.99)

.02

1.24 (0.82–1.86)

.3003

  rPEG

2.54 (1.48–4.33)

.00

1.75 (0.67–4.58)

.25

2.07 (1.25–3.43)

.0038

 Chemotherapy, yes (vs no)

  Neoadjuvant

1.53 (0.83–2.83)

.57

2.82 (1.20–6.60)

.01

1.26 (0.69–2.31)

.4535

  Concomitant

1.22 (0.61–2.43)

.16

2.08 (0.50–8.76)

.30

0.59 (0.35–1.02)

.054

 Baseline BMI, kg/m2

  ≤ 18.5

1.11 (0.27–4.54)

.89

1.46 (0.20–10.8)

.71

3.42 (1.23–9.50)

.0115

  > 18.5–< 25

0.70 (0.41–1.22)

.20

0.73 (0.30–1.73)

.46

0.94 (0.56–1.58)

.8135

  ≥ 25

1.39 (0.81–2.38)

.22

1.29 (0.55–3.02)

.55

0.88 (0.53–1.47)

.6231

Multivariate

 Model 1 for TRUH1

  ECOG 2/3

1.73 (0.93–3.23)

.10

–

–

–

–

  > 40 pack-years

1.94 (1.17–3.20)

.01

–

–

–

–

  Bilateral ND

1.69 (1.02–2.78)

.04

–

–

–

–

Model 2 for TRUH2

  ECOG 2/3

–

–

2.77 (1.23–6.27)

.03

–

–

  pPEG

–

–

2.06 (0.87–4.91)

.09

–

–

  Neoadjuvant CX

–

–

3.27 (1.38–7.74)

.02

–

–

 Model 3 for OS

  Age > 80 years

–

–

–

–

4.25 (2.26–7.99)

.00

  ECOG 2/3

–

–

–

–

1.64 (0.94–2.85)

.10

  rPEG

–

–

–

–

1.95 (1.18–3.25)

.02

  1. P values in bold are significant at P < 0.05
  2. BMI body mass index, CI confidence interval, ECOG PS Eastern Cooperative Oncology Group performance status, HR hazard ratio, OS overall survival, TRUH treatment-related unplanned hospitalization, TRUH1 first TRUH event, TRUH2 second TRUH event, pPEG prophylactic percutaneous endoscopic gastrostomy, rPEG Reactive percutaneous endoscopic gastrostomy, ND neck dissection, CX chemotherapy